With Alzheimer’s disease medical professionals have to conduct costly brain imaging scans, and sometimes, invasive cerebral spinal fluid tests to rule out other diseases.  Now, a new study from researchers at Tel Aviv University and Harvard University makes a massive leap forward in the process of effectively screening and diagnosing Alzheimer’s disease. The team state that their findings propose a new biomarker for cognitive aging … Continue reading Human study identifies biomarker in blood for Alzheimer’s disease.